Patient Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001854794

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Samantha McLemore — tracked via quarterly SEC 13F filings · All famous investors

MidConsumer TiltHigh Turnover how tags are computed

Q4 2023 · 42 positions · Total reported value $1.88B · Top-10 concentration 48.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.0% · 3 new · 23 cut · 3 exited

Active Share (vs S&P 500): 80.6% · vs QQQ: 81.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +3.9% · vs SPY +1.8% · Prev Value $2.99B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.6% · Latest Value $2.96B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, Patient Capital Management, LLC disclosed 42 equity positions with a combined reported value of $1.88B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.1% of reported value. HoldingsHub classifies the profile as Mid / Consumer Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were EXPE ($142.00M), AMZN ($109.74M), OMF ($105.73M). By sector, the heaviest allocations are Consumer Discretionary 41.1%, Financials 25.5%. Versus the prior quarter, allocation shifted toward Health Care (+4.8pp), Financials (+2.3pp) and away from Utilities (-0.5pp), Energy (-1.2pp).

Versus the prior quarter, Patient Capital Management, LLC opened 3 new positions, trimmed 23 and fully exited 3, a turnover rate of 69.0% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q4 2023 were CROX ($39.42M), RPRX ($35.25M), ILMN ($33.51M).

Of the 3 positions fully exited versus the prior quarter, the largest were SPLK ($42.44M), OVV ($34.77M), DXC ($24.96M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • CROX CROCS INC · $39.42M
  • RPRX ROYALTY PHARMA PLC · $35.25M
  • ILMN ILLUMINA INC · $33.51M
  • SDRL SEADRILL LTD · $31.33M
  • SPY STATE STR SPDR S&P 500 ETF T · $994.03K

Fully Exited (vs previous quarter)

  • SPLK SPLUNK INC · prev qtr: $42.44M
  • OVV OVINTIV INC · prev qtr: $34.77M
  • DXC DXC TECHNOLOGY CO · prev qtr: $24.96M

Insider Transactions (Form 4)

Latest Samantha McLemore buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Patient Capital Management, LLC is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $2.99B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-118170 (status: Approved), registered 2020-03-05
  • Regulatory AUM (Form ADV): $2.50B as of 2026-03-27
  • Client mix (by RAUM): registered investment companies 85%, pension and profit-sharing plans 9%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: patientcapitalmanagement.com

Portfolio Structure

  • 39 positions · $2.99B reported value (Q2 2026)
  • Top 10 holdings = 52.4% of reported value
  • Largest position: RPRX (ROYALTY PHARMA PLC) at 6.8%
  • Average position size: $76.65M

Sector Tilt

  • Consumer Discretionary 28.4%
  • Health Care 19.9%
  • Financials 17.9%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 2 new, 10 added, 18 reduced, 2 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 25.5%
Technology 8.0%
Energy 5.1%
Utilities 4.1%
Other 7.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 935.49K $142.00M 7.54%
7.54%
Reduce
2 722.23K $109.74M 5.82%
5.82%
Reduce
3 2.15M $105.73M 5.61%
5.61%
Hold
4 1.89M $97.19M 5.16%
5.16%
Hold
5 600.59K $83.90M 4.45%
4.45%
Reduce
6 5.61M $77.43M 4.11%
4.11%
Hold
7 1.91M $76.98M 4.08%
4.08%
Add
8 2.45M $75.73M 4.02%
4.02%
Reduce
9 1.37M $71.60M 3.80%
3.80%
Add
10 1.87M $67.04M 3.56%
3.56%
Add
11 188.42K $66.69M 3.54%
3.54%
Hold
12 3.29M $62.10M 3.29%
3.29%
Reduce
13 2.53M $50.77M 2.69%
2.69%
Hold
14 1.22M $50.38M 2.67%
2.67%
Add
15 600.98K $47.45M 2.52%
2.52%
Reduce
16 268.41K $45.66M 2.42%
2.42%
Reduce
17 3.84M $45.54M 2.42%
2.42%
Add
18 576.46K $44.68M 2.37%
2.37%
Reduce
19 1.12M $43.87M 2.33%
2.33%
Reduce
20 6.36M $42.70M 2.27%
2.27%
Add
21 321.89K $42.21M 2.24%
2.24%
Reduce
22 232.02K $40.35M 2.14%
2.14%
Reduce
23 422.01K $39.42M 2.09%
2.09%
New
24 6.20M $37.74M 2.00%
2.00%
Add
25 3.78M $37.58M 1.99%
1.99%
Add
26 581.73K $35.82M 1.90%
1.90%
Reduce
27 1.25M $35.25M 1.87%
1.87%
New
28 256.68K $34.10M 1.81%
1.81%
Reduce
29 240.68K $33.51M 1.78%
1.78%
New
30 662.57K $31.33M 1.66%
1.66%
New
31 456.88K $30.06M 1.59%
1.59%
Hold
32 15.98M $21.42M 1.14%
1.14%
Add
33 273.71K $21.06M 1.12%
1.12%
Reduce
34 1.03M $20.97M 1.11%
1.11%
Reduce
35 356.68K $5.16M 0.27%
0.27%
Reduce
36 11.63K $3.68M 0.20%
0.20%
Reduce
37 12.50K $1.68M 0.09%
0.09%
Hold
38 10.00K $1.55M 0.08%
0.08%
Hold
39 40.00K $1.38M 0.07%
0.07%
Hold
40 100.00K $1.04M 0.06%
0.06%
Reduce
41 2.09K $994.03K 0.05%
0.05%
New
42 250.00K $930.00K 0.05%
0.05%
Hold

FAQ

What did Patient Capital Management, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, Patient Capital Management, LLC reported 42 equity positions worth $1.88B in aggregate; its largest disclosed positions were EXPE ($142.00M), AMZN ($109.74M), OMF ($105.73M).

How large is Patient Capital Management, LLC's portfolio?

Patient Capital Management, LLC reported $1.88B of long equity holdings across 42 positions as of 2023-Q4. Top-10 holdings account for 48.1% of reported value.

What is Patient Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/patient-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →